3560 results for «399»
3560 results
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
TAVI in complex anatomy: high stakes and tight spaces
12 Sep 2025 – From PCR Rio Valves 2025
Address the high-stakes challenges of TAVI in complex anatomical scenarios. This session discusses high-risk valve-in-valve interventions, management of delayed coronary obstruction, procedures in small annuli, and innovative bailout strategies including carotid TAVI.
Clinical puzzles in structural interventions
11 Sep 2025 – From PCR Rio Valves 2025
Delve into complex clinical puzzles encountered in structural heart interventions. This session presents comparative outcomes in paradoxical low flow versus high gradient severe aortic stenosis post-TAVI, explores manual and automatic CT measurement techniques, evaluates valve-in-valve procedures within mechanical valves through meta-analysis, and discusses TAVI strategies in...
Tricuspid valve - How to evaluate?
12 Sep 2025 – From PCR Rio Valves 2025
This session offers a detailed evaluation framework for the tricuspid valve, encompassing clinical decision-making, anatomical assessment with 2D and 3D imaging, quantification of regurgitation, and differentiation of secondary and device-related tricuspid regurgitation, supported by advanced imaging software techniques.
TAVI cases: the unexpected and the unseen
11 Sep 2025 – From PCR Rio Valves 2025
Explore this session to uncover complex and unexpected challenges encountered during TAVI procedures. Cases include incidental findings such as aortic valve annulus pseudoaneurysm, double coronary artery perforation in severe aortic stenosis, and unique scenarios involving self-expanding valve implantation and transseptal access. Learn strategies for managing bioprosthesis...
TAVI outcomes in special clinical settings: cancer, diabetes, and frailty
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of TAVI outcomes in special clinical populations including patients with cancer, diabetes, and frailty. This session reviews critical analyses and meta-analyses addressing ischemic cerebrovascular events post-TAVI, and compares mortality and post-procedural outcomes between diabetic and non-diabetic patients, providing valuable insights for personalized...
TMVR today: devices, challenges, and clinical learnings
12 Sep 2025 – From PCR Rio Valves 2025
Explore the evolving landscape of transcatheter mitral valve replacement (TMVR) with a focus on innovative devices, procedural challenges, and clinical learnings. Through a series of case reports, including novel atrial fixation prostheses, devices addressing left ventricular outflow tract obstruction, and complex MitraClip interventions, this session highlights...
Mitral TEER intraprocedural guidance
11 Sep 2025 – From PCR Rio Valves 2025
This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.
Minimalist approach to tricuspid valve therapy
11 Sep 2025 – From PCR Rio Valves 2025
This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...
Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management
11 Sep 2025 – From PCR Rio Valves 2025
This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...
A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients
22 May 2025 – From EuroPCR 2025
This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes
20 May 2025 – From EuroPCR 2025
In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...
Mitral and tricuspid hotline: long-term outcomes
20 May 2025 – From EuroPCR 2025
Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.
Enhancing clipping solutions for durable long-term patient outcomes
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...
